Statins increase the frequency of circulating CD4+FOXP3+ regulatory T cells in healthy individuals

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Rodríguez Perea, Ana Lucía ^a   Montoya, Carlos J ^a   Olek, Sven ^b   Chougnet, Claire A ^c   Velilla, Paula A ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b EPIONTIS GMBH   (Germany)

^c CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CHOLESTEROL; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; KI 67 ANTIGEN; MEVINOLIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; COLORIMETRY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LIPID METABOLISM; LYMPHOCYTE DIFFERENTIATION; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RNA ISOLATION; T LYMPHOCYTE SUBPOPULATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; X CHROMOSOME INACTIVATION; BLOOD; CD4 LYMPHOCYTE COUNT; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; YOUNG ADULT;

ADULT; CD4 LYMPHOCYTE COUNT; CHOLESTEROL, HDL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HEALTHY VOLUNTEERS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOPHENOTYPING; LIPID METABOLISM; LIPIDS; MALE; PHENOTYPE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84924587826     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/762506     Document Type: Article

References (76)

1. 3+ regulatory T cells in search of origin, distinction, and function," Frontiers in Immunology, Vol. 4, article 253, Article ID Article 253, 2013.
2. A. K. Abbas, C. Benoist, J. A. Bluestone et al., "Regulatory T cells: recommendations to simplify the nomenclature," Nature Immunology, Vol. 14, no. 4, pp. 307-308, 2013.
3. + conventional T cells," European Journal of Immunology, Vol. 37, no. 9, pp. 2378-2389, 2007.
4. + T cells," European Journal of Immunology, Vol. 37, no. 1, pp. 129-138, 2007.
5. M. Kmieciak, M. Gowda, L. Graham et al., "Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function," Journal of Translational Medicine, Vol. 7, article 89, 2009.
6. G. A. M. Povoleri, C. Scottá, E. A. Nova-Lamperti, S. John, G. Lombardi, and B. Afzali, "Thymic versus induced regulatory T cells-who regulates the regulators?" Frontiers in Immunology, Vol. 4, article 169, 2013.
7. A. Liesz, E. Suri-Payer, C. Veltkamp et al., "Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke," Nature Medicine, Vol. 15, no. 2, pp. 192-199, 2009.
8. J. Greenwood, L. Steinman, and S. S. Zamvil, "Statin therapy and autoimmune disease: from protein prenylation to immunomodulation," Nature Reviews Immunology, Vol. 6, no. 5, pp. 358-370, 2006.
9. + T cells," Atherosclerosis, Vol. 197, no. 2, pp. 829-839, 2008.
10. T.-T. Tang, Y. Song, Y.-J. Ding et al., "Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis," Journal of Lipid Research, Vol. 52, no. 5, pp. 1023-1032, 2011.
11. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction," Journal of Immunology, Vol. 178, no. 4, pp. 2572-2578, 2007.
12. P. Presicce, M. E. Moreno-Fernandez, C. S. Lages, K. I. Orsborn, and C. A. Chougnet, "Association of two clones allows for optimal detection of human FOXP3," Cytometry Part A, Vol. 77, no. 6, pp. 571-579, 2010.
13. J. Sehouli, C. Loddenkemper, T. Cornu et al., "Epigenetic quan-tification of tumor-infiltrating T-lymphocytes," Epigenetics, Vol. 6, no. 2, pp. 236-246, 2011.
14. Y. Wu, M. Borde, V. Heissmeyer et al., "FOXP3 controls regulatory T cell function through cooperation with NFAT," Cell, Vol. 126, no. 2, pp. 375-387, 2006.
15. A. Yilmaz, C. Reiss, A. Weng et al., "Differential effects of statins on relevant functions of human monocyte-derived dendritic cells," Journal of Leukocyte Biology, Vol. 79, no. 3, pp. 529-538, 2006.
16. X. Peng, J. Jin, S. Giri et al., "Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis," Journal of Neuroimmunology, Vol. 178, no. 1-2, pp. 130-139, 2006.
17. + T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodefi-ciency virus strain 89.6p-infected macaques," Journal of General Virology, Vol. 90, no. 4, pp. 915-926, 2009.
18. A. E. Sousa, J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. M. Victorino, "CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load," Journal of Immunology, Vol. 169, no. 6, pp. 3400-3406, 2002.
19. R. Ghittoni, L. Patrussi, K. Pirozzi et al., "Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases," The FASEB Journal, Vol. 19, no. 6, pp. 605-607, 2005.
20. + regulatory T cells," Journal of Immunology, Vol. 177, no. 4, pp. 2186-2194, 2006.
21. E. Mira, B. León, D. F. Barber et al., "Statins induce regulatory T cell recruitment via a CCL1 dependent pathway," The Journal of Immunology, Vol. 181, no. 5, pp. 3524-3534, 2008.
22. J. E. Feig, Y. Shang, N. Rotllan et al., "Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages," PLoS ONE, Vol. 6, no. 12, Article ID e28534, 2011.
23. + T regulatory cells by modulation of transforming growth factor-β signal transduction," Immunology, Vol. 130, no. 4, pp. 484-493, 2010.
24. L. L. Kodach, R. J. Jacobs, P. W. Voorneveld et al., "Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway," Gut, Vol. 60, no. 11, pp. 1544-1553, 2011.
25. N. Ohkura, M. Hamaguchi, H. Morikawa et al., "T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development," Immunity, Vol. 37, no. 5, pp. 785-799, 2012.
26. J. Rodríguez-Vita, E. Sínchez-Galín, B. Santamaría et al., "Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation," PLoS ONE, Vol. 3, no. 12, Article ID e3959, 2008.
27. 1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin," Journal of the American College of Cardiology, Vol. 39, no. 11, pp. 1752-1757, 2002.
28. + regulatory T cells using a novel cell-based high throughput screening assay," Biochemical Pharmacology, Vol. 85, no. 10, pp. 1513-1524, 2013.
29. + regulatory T cells by TGF-beta induction of transcription factor Foxp3," The Journal of Experimental Medicine, Vol. 198, no. 12, pp. 1875-1886, 2003.
30. M.-F. Zhao, X.-J. Qu, J.-L. Qu et al., "The role of E3 ubiqui-tin ligase Cbl proteins in interleukin-2-induced Jurkat T-cell activation," BioMed Research International, Vol. 2013, Article ID 430861, 8 pages, 2013.
31. S. Yamashita, K. Tsubakio-Yamamoto, T. Ohama, Y. Nakagawa-Toyama, and M. Nishida, "Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions," Journal of Atherosclerosis and Thrombosis, Vol. 17, no. 5, pp. 436-451, 2010.
32. A. J. Wilhelm, M. Zabalawi, J. S. Owen et al., "Apolipoprotein AI modulates regulatory T cells in autoimmune LDLr -/-, ApoA-I-/- mice," The Journal of Biological Chemistry, Vol. 285, no. 46, pp. 36158-36169, 2010.
33. F. Mahmoud and E. Al-Ozairi, "inflammatory cytokines and the risk of cardiovascular complications in type 2 diabetes," Disease Markers, Vol. 35, no. 4, pp. 235-241, 2013.
34. H. Kaji, "High-density lipoproteins and the immune system," Journal of Lipids, Vol. 2013, Article ID 684903, 8 pages, 2013.
35. + regulatory T cells promotes hypercholesterolemia and atherosclerosis," Journal of Clinical Investigation, Vol. 123, no. 3, pp. 1323-1334, 2013.
36. D. A. Forero-Peña and F. R. S. Gutierrez, "Statins as modulators of regulatory T-cell biology," Mediators of inflammation, Vol. 2013, Article ID 167086, 10 pages, 2013.
37. M. J. Pencina, A. M. Navar-Boggan, R. B. D'Agostino Sr. et al., "Application of new cholesterol guidelines to a population-based sample," The New England Journal of Medicine, Vol. 370, no. 15, pp. 1422-1431, 2014.
38. I. K. Gratz and D. J. Campbell, "Organ-specific and memory treg cells: specificity, development, function, and maintenance," Frontiers in Immunology, Vol. 5, article 333, 2014.
39. 3+ regulatory T cells in search of origin, distinction, and function," Frontiers in Immunology, Vol. 4, article 253, Article ID Article 253, 2013.
40. A. K. Abbas, C. Benoist, J. A. Bluestone et al., "Regulatory T cells: recommendations to simplify the nomenclature," Nature Immunology, Vol. 14, no. 4, pp. 307-308, 2013.
41. + conventional T cells," European Journal of Immunology, Vol. 37, no. 9, pp. 2378-2389, 2007.
42. + T cells," European Journal of Immunology, Vol. 37, no. 1, pp. 129-138, 2007.
43. M. Kmieciak, M. Gowda, L. Graham et al., "Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function," Journal of Translational Medicine, Vol. 7, article 89, 2009.
44. G. A. M. Povoleri, C. Scottá, E. A. Nova-Lamperti, S. John, G. Lombardi, and B. Afzali, "Thymic versus induced regulatory T cells-who regulates the regulators?" Frontiers in Immunology, Vol. 4, article 169, 2013.
45. A. Liesz, E. Suri-Payer, C. Veltkamp et al., "Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke," Nature Medicine, Vol. 15, no. 2, pp. 192-199, 2009.
46. J. Greenwood, L. Steinman, and S. S. Zamvil, "Statin therapy and autoimmune disease: from protein prenylation to immunomodulation," Nature Reviews Immunology, Vol. 6, no. 5, pp. 358-370, 2006.
47. + T cells," Atherosclerosis, Vol. 197, no. 2, pp. 829-839, 2008.
48. T.-T. Tang, Y. Song, Y.-J. Ding et al., "Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis," Journal of Lipid Research, Vol. 52, no. 5, pp. 1023-1032, 2011.
49. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction," Journal of Immunology, Vol. 178, no. 4, pp. 2572-2578, 2007.
50. P. Presicce, M. E. Moreno-Fernandez, C. S. Lages, K. I. Orsborn, and C. A. Chougnet, "Association of two clones allows for optimal detection of human FOXP3," Cytometry Part A, Vol. 77, no. 6, pp. 571-579, 2010.
51. J. Sehouli, C. Loddenkemper, T. Cornu et al., "Epigenetic quan-tification of tumor-infiltrating T-lymphocytes," Epigenetics, Vol. 6, no. 2, pp. 236-246, 2011.
52. Y. Wu, M. Borde, V. Heissmeyer et al., "FOXP3 controls regulatory T cell function through cooperation with NFAT," Cell, Vol. 126, no. 2, pp. 375-387, 2006.
53. A. Yilmaz, C. Reiss, A. Weng et al., "Differential effects of statins on relevant functions of human monocyte-derived dendritic cells," Journal of Leukocyte Biology, Vol. 79, no. 3, pp. 529-538, 2006.
54. X. Peng, J. Jin, S. Giri et al., "Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis," Journal of Neuroimmunology, Vol. 178, no. 1-2, pp. 130-139, 2006.
55. + T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodefi-ciency virus strain 89.6p-infected macaques," Journal of General Virology, Vol. 90, no. 4, pp. 915-926, 2009.
56. A. E. Sousa, J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. M. Victorino, "CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load," Journal of Immunology, Vol. 169, no. 6, pp. 3400-3406, 2002.
57. R. Ghittoni, L. Patrussi, K. Pirozzi et al., "Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases," The FASEB Journal, Vol. 19, no. 6, pp. 605-607, 2005.
58. + regulatory T cells," Journal of Immunology, Vol. 177, no. 4, pp. 2186-2194, 2006.
59. E. Mira, B. León, D. F. Barber et al., "Statins induce regulatory T cell recruitment via a CCL1 dependent pathway," The Journal of Immunology, Vol. 181, no. 5, pp. 3524-3534, 2008.
60. J. E. Feig, Y. Shang, N. Rotllan et al., "Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages," PLoS ONE, Vol. 6, no. 12, Article ID e28534, 2011.
61. + T regulatory cells by modulation of transforming growth factor-β signal transduction," Immunology, Vol. 130, no. 4, pp. 484-493, 2010.
62. L. L. Kodach, R. J. Jacobs, P. W. Voorneveld et al., "Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway," Gut, Vol. 60, no. 11, pp. 1544-1553, 2011.
63. N. Ohkura, M. Hamaguchi, H. Morikawa et al., "T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development," Immunity, Vol. 37, no. 5, pp. 785-799, 2012.
64. J. Rodríguez-Vita, E. Sínchez-Galín, B. Santamaría et al., "Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation," PLoS ONE, Vol. 3, no. 12, Article ID e3959, 2008.
65. 1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin," Journal of the American College of Cardiology, Vol. 39, no. 11, pp. 1752-1757, 2002.
66. + regulatory T cells using a novel cell-based high throughput screening assay," Biochemical Pharmacology, Vol. 85, no. 10, pp. 1513-1524, 2013.
67. + regulatory T cells by TGF-beta induction of transcription factor Foxp3," The Journal of Experimental Medicine, Vol. 198, no. 12, pp. 1875-1886, 2003.
68. M.-F. Zhao, X.-J. Qu, J.-L. Qu et al., "The role of E3 ubiqui-tin ligase Cbl proteins in interleukin-2-induced Jurkat T-cell activation," BioMed Research International, Vol. 2013, Article ID 430861, 8 pages, 2013.
69. S. Yamashita, K. Tsubakio-Yamamoto, T. Ohama, Y. Nakagawa-Toyama, and M. Nishida, "Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions," Journal of Atherosclerosis and Thrombosis, Vol. 17, no. 5, pp. 436-451, 2010.
70. A. J. Wilhelm, M. Zabalawi, J. S. Owen et al., "Apolipoprotein AI modulates regulatory T cells in autoimmune LDLr -/-, ApoA-I-/- mice," The Journal of Biological Chemistry, Vol. 285, no. 46, pp. 36158-36169, 2010.
71. F. Mahmoud and E. Al-Ozairi, "inflammatory cytokines and the risk of cardiovascular complications in type 2 diabetes," Disease Markers, Vol. 35, no. 4, pp. 235-241, 2013.
72. H. Kaji, "High-density lipoproteins and the immune system," Journal of Lipids, Vol. 2013, Article ID 684903, 8 pages, 2013.
73. + regulatory T cells promotes hypercholesterolemia and atherosclerosis," Journal of Clinical Investigation, Vol. 123, no. 3, pp. 1323-1334, 2013.
74. D. A. Forero-Peña and F. R. S. Gutierrez, "Statins as modulators of regulatory T-cell biology," Mediators of inflammation, Vol. 2013, Article ID 167086, 10 pages, 2013.
75. M. J. Pencina, A. M. Navar-Boggan, R. B. D'Agostino Sr. et al., "Application of new cholesterol guidelines to a population-based sample," The New England Journal of Medicine, Vol. 370, no. 15, pp. 1422-1431, 2014.
76. I. K. Gratz and D. J. Campbell, "Organ-specific and memory treg cells: specificity, development, function, and maintenance," Frontiers in Immunology, Vol. 5, article 333, 2014.